3.72
price up icon3.91%   0.14
 
loading
Schlusskurs vom Vortag:
$3.58
Offen:
$3.58
24-Stunden-Volumen:
2.48M
Relative Volume:
1.94
Marktkapitalisierung:
$642.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.70M
KGV:
-11.27
EPS:
-0.33
Netto-Cashflow:
$-51.36M
1W Leistung:
+13.41%
1M Leistung:
+37.78%
6M Leistung:
+43.08%
1J Leistung:
-18.06%
1-Tages-Spanne:
Value
$3.58
$3.83
1-Wochen-Bereich:
Value
$3.21
$3.83
52-Wochen-Spanne:
Value
$1.89
$4.70

Savara Inc Stock (SVRA) Company Profile

Name
Firmenname
Savara Inc
Name
Telefon
51285113796
Name
Adresse
6836 BEE CAVE ROAD, AUSTIN, TX
Name
Mitarbeiter
59
Name
Twitter
@SavaraPharma
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
SVRA's Discussions on Twitter

Vergleichen Sie SVRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SVRA
Savara Inc
3.72 618.76M 0 -54.70M -51.36M -0.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Savara Inc Stock (SVRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-15 Hochstufung H.C. Wainwright Neutral → Buy
2025-05-29 Herabstufung H.C. Wainwright Buy → Neutral
2024-12-20 Eingeleitet Wells Fargo Overweight
2024-11-13 Herabstufung Evercore ISI Outperform → In-line
2024-02-15 Eingeleitet JMP Securities Mkt Outperform
2023-11-07 Eingeleitet Guggenheim Buy
2023-05-16 Hochstufung Jefferies Hold → Buy
2023-03-31 Herabstufung Jefferies Buy → Hold
2021-03-16 Eingeleitet Piper Sandler Overweight
2021-03-15 Eingeleitet Oppenheimer Outperform
2019-06-13 Bestätigt H.C. Wainwright Buy
2019-06-13 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2019-06-13 Herabstufung Ladenburg Thalmann Buy → Neutral
2018-08-13 Fortgesetzt ROTH Capital Neutral
2018-01-03 Eingeleitet Ladenburg Thalmann Buy
2017-09-27 Fortgesetzt ROTH Capital Buy
2017-09-22 Eingeleitet Jefferies Buy
2017-09-11 Eingeleitet JMP Securities Mkt Outperform
Alle ansehen

Savara Inc Aktie (SVRA) Neueste Nachrichten

pulisher
Sep 06, 2025

Trend analysis for Savara Inc. this weekShare Buyback & Daily Oversold Bounce Ideas - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Savara Showcases Promising Phase 3 Trial Data for Molgramostim at ATS 2025 - MSN

Sep 06, 2025
pulisher
Sep 06, 2025

What are the risks of holding Savara Inc.July 2025 News Drivers & AI Enhanced Trade Execution Alerts - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Regression analysis insights on Savara Inc. performanceJuly 2025 Breakouts & Weekly Setup with High ROI Potential - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Can Savara Inc. grow without external fundingWeekly Market Outlook & AI Forecasted Entry/Exit Points - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Is Savara Inc. subject to activist investor interestMarket Movers & Real-Time Stock Entry Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Will Savara Inc. stock go up soonMarket Volume Report & Expert Curated Trade Setups - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What high frequency data says about Savara Inc.Weekly Trend Summary & Consistent Growth Equity Picks - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Savara Inc. to Present at Upcoming Healthcare Investor Conferences - MSN

Sep 05, 2025
pulisher
Sep 05, 2025

H.C. Wainwright raises Savara stock price target to $8 on larger patient pool By Investing.com - Investing.com South Africa

Sep 05, 2025
pulisher
Sep 05, 2025

Savara Inc. stock chart pattern explainedIPO Watch & Reliable Entry Point Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Published on: 2025-09-05 01:53:57 - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

H.C. Wainwright raises Savara stock price target to $8 on larger patient pool - Investing.com Canada

Sep 05, 2025
pulisher
Sep 04, 2025

Price action breakdown for Savara Inc.July 2025 Decliners & Daily Stock Trend Reports - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What candlestick patterns are forming on Savara Inc.2025 Key Lessons & Weekly Top Gainers Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Is Savara Inc. stock a value trapWeekly Market Outlook & Weekly High Return Opportunities - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

What’s the recovery path for long term holders of Savara Inc.Treasury Yields & Low Drawdown Trading Techniques - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What machine learning models say about Savara Inc.Trade Analysis Report & Momentum Based Trading Ideas - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Savara (SVRA) Surges 3.32% on Analyst Upgrade and Positive Phase 3 Trial Data - AInvest

Sep 04, 2025
pulisher
Sep 03, 2025

Movement Recap: Is Savara Inc. stock a good dividend stockWeekly Risk Summary & Fast Entry and Exit Trade Plans - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Sector ETF performance correlation with Savara Inc.Weekly Gains Report & Community Trade Idea Sharing - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Savara Inc. continue its uptrendWeekly Investment Recap & Smart Investment Allocation Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Savara’s Expanding aPAP Market and Strategic Moves Justify Buy Rating with Increased Price Target - TipRanks

Sep 03, 2025
pulisher
Sep 03, 2025

Leading vs lagging indicators on Savara Inc. performanceTake Profit & Growth Focused Stock Pick Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Market reaction to Savara Inc.’s recent newsQuarterly Trade Summary & Daily Price Action Insights - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Comparing Savara Inc. in custom built stock radarsJuly 2025 Movers & Safe Capital Growth Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Savara Inc. stock poised for growth2025 EndofYear Setup & Technical Confirmation Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How institutional ownership impacts Savara Inc. stockEarnings Growth Report & Free Expert Verified Stock Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Savara Highlights MOLBREEVI Development in New Presentation - TipRanks

Sep 02, 2025
pulisher
Sep 02, 2025

Will a bounce in Savara Inc. offer an exitJuly 2025 Breakouts & Real-Time Market Trend Scan - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Savara Announces New U.S. Health Claims Data Analysis Finds Over 50% Increase in the Estimated Numbe - PharmiWeb.com

Sep 02, 2025
pulisher
Sep 02, 2025

Does Savara Inc. stock reflect fundamentals2025 Market WrapUp & Weekly Top Gainers Trade List - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

50% Jump in Rare Lung Disease Patients: Savara Finds 5,500 U.S. Cases Ahead of FDA Drug Review - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

Can Savara Inc. reach all time highs this yearMarket Growth Summary & Weekly Return Optimization Plans - خودرو بانک

Sep 02, 2025
pulisher
Sep 01, 2025

Savara’s SWOT analysis: molbreevi’s potential reshapes rare respiratory stock outlook - Investing.com

Sep 01, 2025
pulisher
Sep 01, 2025

Earnings Chart Overlay Points to Savara Inc. Upside getLinesFromResByArray error: size == 0 - 강소기업뉴스

Sep 01, 2025
pulisher
Sep 01, 2025

Will Savara Inc. announce a stock split2025 Technical Overview & Precise Swing Trade Alerts - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Quant Funds Rotate Into Savara Inc. StockJuly 2025 Summary & Verified High Yield Trade Plans - beatles.ru

Sep 01, 2025
pulisher
Sep 01, 2025

Earnings visualization tools for Savara Inc.Weekly Profit Report & Daily Volume Surge Trade Alerts - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 18:39:16 - Newser

Aug 31, 2025

Finanzdaten der Savara Inc-Aktie (SVRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):